• Personal Information
  • Academic Qualifications
  • Research Interests
  • Teaching Experiences
  • Participation In Scientific Conferences, Meetings & Workshops
  • Research Projects and Grants
  • Supervision and Training
  • Publications, Presentations and Posters
  • Conference Papers and Posters
  • Chapter & Books
  • Other Establishments

Conference Papers and Posters

61. Ikram Guizani, El-Amine W, Lahmadi R, Chakroun AS, Talbi C, Bakhiet S, Cupolillo E, Mukhtar M . Simple Pcr Assays For Identification/ Differentiation of Parasites of The Leishmania Donovani Complex . 4th World Congress on Leishmaniasis (2009).

62. Sahar   Bakhiet, Elwaleed M. Elamin, Ahmed M. Elhassan and Maowia M Mukhtar. CLUSTERING OF SUDANESE LEISHMANIA ISOLATES USING RAPD .4th world congress on leishmaniasis (2009).

63. Elamin WM, Guerbouj S, Guizani I, Bakhiet SM, El-Hassan SM, El_Hassan AM, Musa AM, Kheir MM and Mukhtar MM. Leishmania archibaldi is the major cause of leishmaniasis in Sudan. Oral presentation and abstract. Conference on endemic and infectious diseases in Sudan, Ministry of Science and Technology, National Centre for Research, Tropical Medicine Research Institute, Institute of Endemic Diseases, WHO/TDR and Federal Ministry of Health, Sudan. Sharja Hall 5-8 May 2003.

64. Maowia M. Mukhtar, Dina T. Eltayeb, Sahar M. Bakhiet, El Waleed M. Elamin. The cytokine profiles of Sudanese patients with different clinical forms of leishmaniasis. 5th World Leish May 2013. Brazil

65. Enaam Hussein, Ahmed Mohamed EL Hassan, Sahar Mubarak Bakhiet. Epstein – Barr virus Expression in Hodgkin’s Lymphoma in Sudan. 23rd Congress of the European Hematology Association to be held in Stockholm, Sweden, 2018

66. Bakhiet SM. The Mycetoma Research Gaps Seminar (2017): Diagnostic Gaps in Mycetoma

67. Najwa A Mhmoud, Sarah Abdalla Ahmed, Lim W4. Sahar Mubarak Bakhiet, Ahmed Fahal, Wendy W. J. van de Sande. Collariella causiiformis , a novel agent of human eumycetoma with yellow grains, 6th international conference of Mycetoma

68. Brüggemann R, Nyaoke B, Saad ES, Bakhiet SM, Fahal AH. A randomized, double-blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—pharmacokinetic results. ISHAM 2022, DOI: 10.1093/mmy/myac072.S4.5b

69. Siddig SS, Nyaoke B, Saad ES, Bakhiet SM, Fahal AH. P445 Clinical evaluation of the performance of the most commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the golden standard. ISHAM 2022, DOI: 10.1093/mmy/myac072.P445